For instance, while IDH1 mutations were more common in low-grade gliomas, they were occasionally observed in high-grade tumors as well, and they were independently associated with prolonged survival in both cohorts (Figure 1—figure supplement 7C). The gene discussed is IDH1; the disease is central nervous system cancer.